Lista de obras -

Action blind: disturbed self-other integration in schizophrenia

artículo científico publicado en 2012

Add-on Antidepressants in the Naturalistic Treatment of Schizophrenia Spectrum Disorder - When, Who, and How?

artículo científico publicado en 2017

Akathisia and suicidal ideation in first-episode schizophrenia

artículo científico publicado en 2012

An early improvement threshold to predict response and remission in first-episode schizophrenia

artículo científico publicado en 2010

Associations of NEUROD2 polymorphisms and change of cognitive dysfunctions in schizophrenia and schizoaffective disorder after eight weeks of antipsychotic treatment

artículo científico publicado en 2017

Associations of SNAP-25 polymorphisms with cognitive dysfunctions in Caucasian patients with schizophrenia during a brief trail of treatment with atypical antipsychotics

artículo científico publicado en 2008

Attitude towards adherence in patients with schizophrenia at discharge

artículo científico publicado en 2009

Atypical symptoms in hospitalised patients with major depressive episode: frequency, clinical characteristics, and internal validity

artículo científico publicado en 2007

Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia

artículo científico publicado en 2002

COX-2 inhibition as a treatment approach in schizophrenia: immunological considerations and clinical effects of celecoxib add-on therapy

artículo científico publicado en 2004

Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment

artículo científico publicado en 2010

Clinical predictors of response and remission in inpatients with depressive syndromes

artículo científico publicado en 2011

Cognitive functioning in euthymic bipolar I and bipolar II patients

artículo científico publicado en 2008

Combining the categorical and the dimensional perspective in a diagnostic map of psychotic disorders ⬇️

artículo científico publicado el 30 de julio de 2010

Corrigendum to ‘Action blind: Disturbed self-other integration in schizophrenia [Neuropsychologia 50 (2012), 3775–3780]’

scholarly article published in Neuropsychologia

Creating a map of psychiatric patients based on psychopathological symptom profiles

artículo científico publicado en 2009

Decreased T cellular immune response in schizophrenic patients

artículo científico publicado en 2006

Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders

artículo científico publicado en 2009

Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response

artículo científico publicado en 2008

Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: comparing treatment with risperidone and haloperidol

artículo científico publicado en 2011

Disentangling the adult attention-deficit hyperactivity disorder endophenotype: parametric measurement of attention

artículo científico publicado en 2011

Do efficacy and effectiveness samples differ in antidepressant treatment outcome? An analysis of eligibility criteria in randomized controlled trials

artículo científico publicado en 2010

Does early improvement in major depression protect against treatment emergent suicidal ideation?

artículo científico publicado en 2009

Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression

artículo científico publicado en 2008

Duloxetine in the treatment of major psychiatric and neuropathic disorders

artículo científico publicado en 2008

Early Improvement As a Predictor of Later Response to Antipsychotics in Schizophrenia: A Diagnostic Test Review

artículo científico publicado en 2015

Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms

artículo científico publicado en 2007

Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorder

artículo científico publicado en 2003

Empathy without borders? Cross-cultural heart and mind-reading in first-year medical students ⬇️

artículo científico publicado el 1 de julio de 2013

Evaluating depressive symptoms in schizophrenia: a psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale

artículo científico publicado en 2012

Exploring the structure of psychopathological symptoms: a re-analysis of AMDP data by robust nonmetric multidimensional scaling ⬇️

artículo científico publicado el 8 de noviembre de 2011

Functional Outcomes in Schizophrenia: Employment Status as a Metric of Treatment Outcome ⬇️

artículo científico publicado el 1 de junio de 2012

Genetics of emergent suicidality during antidepressive treatment--data from a naturalistic study on a large sample of inpatients with a major depressive episode

artículo científico publicado en 2012

Homer-1 polymorphisms are associated with psychopathology and response to treatment in schizophrenic patients

artículo científico publicado en 2010

IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia

artículo científico publicado en 2005

Impulsivity is related to striatal dopamine transporter availability in healthy males

artículo científico publicado en 2012

Infectious Agents are Associated with Psychiatric Diseases

artículo científico publicado en 2012

Influencing factors and predictors of early improvement in the acute treatment of schizophrenia and schizophrenia spectrum disorder

artículo científico publicado en 2011

Intact emotion-cognition interaction in schizophrenia patients and first-degree relatives: evidence from an emotional antisaccade task

artículo científico publicado en 2013

Interference control in adult ADHD: No evidence for interference control deficits if response speed is controlled by delta plots ⬇️

artículo científico publicado el 27 de marzo de 2013

Methylphenidate effects on neural activity during response inhibition in healthy humans

artículo científico publicado en 2012

Mirroring everyday clinical practice in clinical trial design: a new concept to improve the external validity of randomized double-blind placebo-controlled trials in the pharmacological treatment of major depression

artículo científico publicado en 2012

Neuropsychological profiles in different at-risk states of psychosis: executive control impairment in the early--and additional memory dysfunction in the late--prodromal state

artículo científico publicado en 2010

No association between the G308A polymorphism of the tumor necrosis factor-alpha gene and schizophrenia

artículo científico publicado en 2002

No influence of brain-derived neurotrophic factor (BDNF) polymorphisms on treatment response in a naturalistic sample of patients with major depression

artículo científico publicado en 2012

One-year functional outcomes of naturalistically treated patients with schizophrenia

artículo científico publicado en 2012

Outcomes of 1014 naturalistically treated inpatients with major depressive episode

artículo científico publicado en 2010

Pleckstrin homology domain containing 6 protein (PLEKHA6) polymorphisms are associated with psychopathology and response to treatment in schizophrenic patients

artículo científico publicado en 2014

Predictors for symptom re-exacerbation after targeted stepwise drug discontinuation in first-episode schizophrenia: Results of the first-episode study within the German research network on schizophrenia

artículo científico publicado en 2015

Predictors of relapse in the year after hospital discharge among patients with schizophrenia

artículo científico publicado en 2012

Predictors of response and remission in the acute treatment of first-episode schizophrenia patients — Is it all about early response?

article by Rebecca Schennach-Wolff et al published May 2011 in European Neuropsychopharmacology

Psychopathological characteristics and treatment response of first episode compared with multiple episode schizophrenic disorders

artículo científico publicado en 2007

QTc prolongation in short-term treatment of schizophrenia patients: effects of different antipsychotics and genetic factors

artículo científico publicado en 2018

Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission?

artículo científico publicado en 2010

Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms

artículo científico publicado en 2005

Quetiapine in the treatment of schizophrenia and related disorders

artículo científico publicado en 2007

Rates and predictors of remission in first-episode schizophrenia within 1 year of antipsychotic maintenance treatment. Results of a randomized controlled trial within the German Research Network on Schizophrenia

artículo científico publicado en 2013

Relapse prevention in first-episode schizophrenia--maintenance vs intermittent drug treatment with prodrome-based early intervention: results of a randomized controlled trial within the German Research Network on Schizophrenia

artículo científico publicado en 2010

Remission and recovery and their predictors in schizophrenia spectrum disorder: results from a 1-year follow-up naturalistic trial

artículo científico publicado en 2012

Response trajectories in "real-world" naturalistically treated schizophrenia patients

artículo científico publicado en 2012

Review: antidepressants associated with increased risk of suicidality in adults aged less than 25 years

artículo científico

SNAP-25 gene polymorphisms and weight gain in schizophrenic patients

artículo científico publicado en 2008

Safety evaluation of zotepine for the treatment of schizophrenia

scientific article published on July 2010

Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity

artículo científico publicado en 2003

Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia

artículo científico publicado en 2008

Stability of remission rates in a 3-year follow-up of naturalistic treated depressed inpatients

artículo científico publicado en 2016

The CNR1 gene in depression and schizophrenia - is there an association with early improvement and response?

artículo científico publicado en 2012

The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: comparison of psychopathological and psychosocial course and outcome and prediction of chronicity

artículo científico publicado en 2010

The controversial link between antidepressants and suicidality risks in adults: data from a naturalistic study on a large sample of in-patients with a major depressive episode

artículo científico publicado en 2008

The effects of methylphenidate on whole brain intrinsic functional connectivity

artículo científico publicado en 2014

Three-Year long-term outcome of 458 naturalistically treated inpatients with major depressive episode: severe relapse rates and risk factors

artículo científico publicado en 2014

Treatment Response in First-episode Schizophrenia ⬇️

artículo científico publicado el 31 de agosto de 2012

What are residual symptoms in schizophrenia spectrum disorder? Clinical description and 1-year persistence within a naturalistic trial

artículo científico publicado en 2014

Lista de obras de

Action blind: disturbed self-other integration in schizophrenia

Add-on Antidepressants in the Naturalistic Treatment of Schizophrenia Spectrum Disorder - When, Who, and How?

Akathisia and suicidal ideation in first-episode schizophrenia

An early improvement threshold to predict response and remission in first-episode schizophrenia

Associations of NEUROD2 polymorphisms and change of cognitive dysfunctions in schizophrenia and schizoaffective disorder after eight weeks of antipsychotic treatment

Associations of SNAP-25 polymorphisms with cognitive dysfunctions in Caucasian patients with schizophrenia during a brief trail of treatment with atypical antipsychotics

Attitude towards adherence in patients with schizophrenia at discharge

Atypical symptoms in hospitalised patients with major depressive episode: frequency, clinical characteristics, and internal validity

Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia

COX-2 inhibition as a treatment approach in schizophrenia: immunological considerations and clinical effects of celecoxib add-on therapy

Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment

Clinical predictors of response and remission in inpatients with depressive syndromes

Cognitive functioning in euthymic bipolar I and bipolar II patients

Combining the categorical and the dimensional perspective in a diagnostic map of psychotic disorders ⬇️

Corrigendum to ‘Action blind: Disturbed self-other integration in schizophrenia [Neuropsychologia 50 (2012), 3775–3780]’

Creating a map of psychiatric patients based on psychopathological symptom profiles

Decreased T cellular immune response in schizophrenic patients

Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders

Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response

Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: comparing treatment with risperidone and haloperidol

Disentangling the adult attention-deficit hyperactivity disorder endophenotype: parametric measurement of attention

Do efficacy and effectiveness samples differ in antidepressant treatment outcome? An analysis of eligibility criteria in randomized controlled trials

Does early improvement in major depression protect against treatment emergent suicidal ideation?

Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression

Duloxetine in the treatment of major psychiatric and neuropathic disorders

Early Improvement As a Predictor of Later Response to Antipsychotics in Schizophrenia: A Diagnostic Test Review

Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms

Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorder

Empathy without borders? Cross-cultural heart and mind-reading in first-year medical students ⬇️

Evaluating depressive symptoms in schizophrenia: a psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale

Exploring the structure of psychopathological symptoms: a re-analysis of AMDP data by robust nonmetric multidimensional scaling ⬇️

Functional Outcomes in Schizophrenia: Employment Status as a Metric of Treatment Outcome ⬇️

Genetics of emergent suicidality during antidepressive treatment--data from a naturalistic study on a large sample of inpatients with a major depressive episode

Homer-1 polymorphisms are associated with psychopathology and response to treatment in schizophrenic patients

IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia

Impulsivity is related to striatal dopamine transporter availability in healthy males

Infectious Agents are Associated with Psychiatric Diseases

Influencing factors and predictors of early improvement in the acute treatment of schizophrenia and schizophrenia spectrum disorder

Intact emotion-cognition interaction in schizophrenia patients and first-degree relatives: evidence from an emotional antisaccade task

Interference control in adult ADHD: No evidence for interference control deficits if response speed is controlled by delta plots ⬇️

Methylphenidate effects on neural activity during response inhibition in healthy humans

Mirroring everyday clinical practice in clinical trial design: a new concept to improve the external validity of randomized double-blind placebo-controlled trials in the pharmacological treatment of major depression

Neuropsychological profiles in different at-risk states of psychosis: executive control impairment in the early--and additional memory dysfunction in the late--prodromal state

No association between the G308A polymorphism of the tumor necrosis factor-alpha gene and schizophrenia

No influence of brain-derived neurotrophic factor (BDNF) polymorphisms on treatment response in a naturalistic sample of patients with major depression

One-year functional outcomes of naturalistically treated patients with schizophrenia

Outcomes of 1014 naturalistically treated inpatients with major depressive episode

Pleckstrin homology domain containing 6 protein (PLEKHA6) polymorphisms are associated with psychopathology and response to treatment in schizophrenic patients

Predictors for symptom re-exacerbation after targeted stepwise drug discontinuation in first-episode schizophrenia: Results of the first-episode study within the German research network on schizophrenia

Predictors of relapse in the year after hospital discharge among patients with schizophrenia

Predictors of response and remission in the acute treatment of first-episode schizophrenia patients — Is it all about early response?

Psychopathological characteristics and treatment response of first episode compared with multiple episode schizophrenic disorders

QTc prolongation in short-term treatment of schizophrenia patients: effects of different antipsychotics and genetic factors

Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission?

Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms

Quetiapine in the treatment of schizophrenia and related disorders

Rates and predictors of remission in first-episode schizophrenia within 1 year of antipsychotic maintenance treatment. Results of a randomized controlled trial within the German Research Network on Schizophrenia

Relapse prevention in first-episode schizophrenia--maintenance vs intermittent drug treatment with prodrome-based early intervention: results of a randomized controlled trial within the German Research Network on Schizophrenia

Remission and recovery and their predictors in schizophrenia spectrum disorder: results from a 1-year follow-up naturalistic trial

Response trajectories in "real-world" naturalistically treated schizophrenia patients

Review: antidepressants associated with increased risk of suicidality in adults aged less than 25 years

SNAP-25 gene polymorphisms and weight gain in schizophrenic patients

Safety evaluation of zotepine for the treatment of schizophrenia

Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity

Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia

Stability of remission rates in a 3-year follow-up of naturalistic treated depressed inpatients

The CNR1 gene in depression and schizophrenia - is there an association with early improvement and response?

The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: comparison of psychopathological and psychosocial course and outcome and prediction of chronicity

The controversial link between antidepressants and suicidality risks in adults: data from a naturalistic study on a large sample of in-patients with a major depressive episode

The effects of methylphenidate on whole brain intrinsic functional connectivity

Three-Year long-term outcome of 458 naturalistically treated inpatients with major depressive episode: severe relapse rates and risk factors

Treatment Response in First-episode Schizophrenia ⬇️

What are residual symptoms in schizophrenia spectrum disorder? Clinical description and 1-year persistence within a naturalistic trial